Health Care · S&P 500
Charles River Laboratories
A contract research organization providing lab animals and preclinical testing services to drugmakers. S&P 500 constituent. Sector: Health Care (Life Sciences Tools & Services). Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
CRL Updated Jul 11, 2026 2 AI consumers· 2 recurring
Annual return · 2026-07-10'21+50.8%'22-42.2%'23+8.5%'24-21.9%'25+8.1%YTD+17%
Money in ▸·
Charles River Laboratories~$4.05B
▸ Money out·
Financials & Segments
- Total revenue · ~$4.05B (FY2024)
- Segments · Research Models & Services (RMS) · Discovery & Safety Assessment (DSA) · Manufacturing Solutions
Revenue from
No refined links yet.
Pays to
No refined links yet.